Acetaminophen,caffeine And Pyrilamine Maleate
NDC Package 24689-121-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Acetaminophen, Caffeine And Pyrilamine Maleate is a . Marketed by Apnar Pharma Lp, this product is identified by NDC 24689-121 and is authorized under FDA application M013.

Identification & Billing

NDC Package Code
24689-121-01
Package Description
20 TABLET in 1 BOTTLE
Product Code
11-Digit Billing Format
24689012101

Clinical Specifications

Proprietary Name
Acetaminophen, Caffeine And Pyrilamine Maleate
Dosage Form
-

Regulatory & Marketing

Labeler Name
Apnar Pharma Lp
FDA Application #
M013
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
07-05-2022
End Marketing Date
01-22-2025
Listing Expiration
01-22-2025
Exclude Flag
D
Sample Package
No

Hierarchy Structure

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (24689-121). Click a package code to view its specific billing and regulatory data.

500 TABLET in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 24689-121-01 identifies a specific commercial package of 20 tablet in 1 bottle of Acetaminophen, Caffeine And Pyrilamine Maleate, labeled by Apnar Pharma Lp. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Apnar Pharma Lp on July 05, 2022. The current certification is valid through January 22, 2025.

How is this Apnar Pharma Lp product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 24689012101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
24689-121-01
11-Digit CMS (5-4-2)
24689-0121-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.